TEST:

TissueCypher Barrett’s Esophagus Test

The TissueCypher® Barrett’s Esophagus Test is a precision medicine assay developed by Castle Biosciences to assess the risk of progression from Barrett’s esophagus (BE) to high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC). It is designed for patients with endoscopic biopsy-confirmed BE that is graded as non-dysplastic (ND), indefinite for dysplasia (IND), or low-grade dysplasia (LGD).